Fujian Shengdi Pharmaceutical Co., Ltd.

This study tests an investigational drug called HRS-7450 in 208 adults who have had an acute ischemic stroke (a clot blocking blood flow to the brain). Participants must receive the drug or a placebo within 4.5 to 24 hours of their first symptoms. The main goal is to see if the d…

This study tests if HRS9531 can lower blood sugar better than a placebo in people with type 2 diabetes who are already using basal insulin. About 300 adults will receive either HRS9531 or a placebo for 40 weeks. The main goal is to see if HRS9531 improves long-term blood sugar le…

This study tests an investigational drug called HRS9531 in 140 adults with moderate-to-severe obstructive sleep apnea and obesity who already use a breathing machine (PAP therapy). The goal is to see if the drug can reduce breathing pauses during sleep and improve symptoms over 5…

This study tests an injectable drug called HRS9531 in 140 adults with obstructive sleep apnea and obesity who do not use a breathing machine (CPAP). The goal is to see if the drug can reduce breathing pauses during sleep and help with weight loss over 52 weeks. Participants will …

This study tests an experimental injection called HRS-5635, given alone or with other drugs, in 369 adults with chronic hepatitis B. Participants must already be on standard antiviral pills with undetectable virus levels. The main goal is to see if the treatment can lower or clea…

This study tests a new medicine called HRS-9563 for people with mild to moderate high blood pressure. The goal is to see if it safely lowers blood pressure and to find the best dose. About 234 adults will take either the drug or a placebo for up to 9 months.

This study tests two experimental drugs, HRS-7249 and SHR-1918, in people with very high triglycerides (a type of fat in the blood) who are at high risk for acute pancreatitis, a painful and dangerous inflammation of the pancreas. About 108 adults will receive either the drugs or…

This study tests a new medicine called HRS-7249 in 200 adults with high triglycerides (a type of blood fat). The goal is to see if it safely lowers fat levels and to find the best dose. Participants will receive either the drug or a placebo. The trial is for people aged 18 to 79 …

This early-stage study tests a new injection called HRS-5817 in healthy adults, some with obesity and some without. The main goal is to check if the drug is safe and how the body processes it. About 92 volunteers aged 18-55 will receive single or multiple doses under close monito…

This early-stage study tests a new formulation of the drug HRS9531 in healthy men who are overweight or obese. The goal is to compare how the body handles the new versus the old version, and to check for side effects. About 168 participants will take a single dose of the drug, an…

This early-stage study tests a single dose of HRS-2162 injection in 64 healthy adults aged 18-45. The goal is to check if the drug is safe and how the body processes it, with the future aim of reversing muscle paralysis caused by anesthesia. Participants must be in good health an…

This study tests an injectable drug called HRS-9057 in 153 adults hospitalized with heart failure who have fluid buildup causing symptoms like shortness of breath and swelling. The main goal is to see if the drug helps reduce weight (a sign of fluid loss) more than a placebo over…